ECM
ExodusPoint Capital Management Portfolio holdings
AUM
$8.21B
1-Year Return
14.38%
This Quarter Return
+5.67%
1 Year Return
+14.38%
3 Year Return
+47.96%
5 Year Return
+100.26%
10 Year Return
–
AUM
$9.7B
AUM Growth
+$579M
(+6.3%)
Cap. Flow
+$76.6M
Cap. Flow
% of AUM
0.79%
Top 10 Holdings %
Top 10 Hldgs %
20.01%
Holding
2,066
New
706
Increased
386
Reduced
348
Closed
589
Top Buys
| 1 |
Microsoft
MSFT
|
+$386M |
| 2 |
Mondelez International
MDLZ
|
+$131M |
| 3 |
NVIDIA
NVDA
|
+$119M |
| 4 |
Johnson & Johnson
JNJ
|
+$107M |
| 5 |
Medtronic
MDT
|
+$57.9M |
Top Sells
| 1 |
Amazon
AMZN
|
+$292M |
| 2 |
Apple
AAPL
|
+$169M |
| 3 |
Duke Energy
DUK
|
+$75.7M |
| 4 |
ConocoPhillips
COP
|
+$70.6M |
| 5 |
Broadcom
AVGO
|
+$70.5M |
Sector Composition
| 1 | Healthcare | 18.8% |
| 2 | Technology | 16.68% |
| 3 | Utilities | 10.57% |
| 4 | Real Estate | 8.13% |
| 5 | Consumer Discretionary | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Crane Co
CR
$10.7B
| $217K | ﹤0.01% |
+1,370
| New | +$217K |
|
1327
Redwire
RDW
$1.22B
| $217K | ﹤0.01% |
+31,627
| New | +$217K |
|
1328
CEVA Inc
CEVA
$570M
| $216K | ﹤0.01% |
+8,931
| New | +$216K |
|
1329
Medallion Financial
MFIN
$248M
| $215K | ﹤0.01% |
+26,357
| New | +$215K |
|
1330
Verastem
VSTM
$575M
| $215K | ﹤0.01% |
+72,061
| New | +$215K |
|
1331
Cass Information Systems
CASS
$575M
| $214K | ﹤0.01% |
+5,148
| New | +$214K |
|
1332
Nokia
NOK
$24.9B
| $212K | ﹤0.01% |
48,528
+15,092
| +45% | +$65.9K |
|
1333
Enpro
NPO
$4.77B
| $212K | ﹤0.01% |
+1,305
| New | +$212K |
|
|
ESGR
1334
DELISTED
Enstar Group
ESGR
| $211K | ﹤0.01% |
655
-734
| -53% | -$236K |
|
1335
Dentsply Sirona
XRAY
$2.78B
| $208K | ﹤0.01% |
+7,696
| New | +$208K |
|
|
AFCG
1336
AFC Gamma
AFCG
$103M
| $207K | ﹤0.01% |
+20,226
| New | +$207K |
|
1337
Similarweb
SMWB
$848M
| $207K | ﹤0.01% |
+23,405
| New | +$207K |
|
1338
Kyverna Therapeutics
KYTX
$179M
| $205K | ﹤0.01% |
+41,984
| New | +$205K |
|
1339
Lifecore Biomedical
LFCR
$291M
| $205K | ﹤0.01% |
+41,529
| New | +$205K |
|
1340
Riskified
RSKD
$732M
| $205K | ﹤0.01% |
+43,334
| New | +$205K |
|
1341
Array Technologies
ARRY
$1.2B
| $203K | ﹤0.01% |
+30,813
| New | +$203K |
|
1342
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$3.72B
| $203K | ﹤0.01% |
8,000
| – | – |
|
|
NXDR
1343
Nextdoor Holdings
NXDR
$794M
| $201K | ﹤0.01% |
+80,935
| New | +$201K |
|
1344
Utz Brands
UTZ
$1.12B
| $195K | ﹤0.01% |
11,036
-89,309
| -89% | -$1.58M |
|
1345
Standard BioTools
LAB
$508M
| $194K | ﹤0.01% |
+100,309
| New | +$194K |
|
1346
SFL Corp
SFL
$1.1B
| $193K | ﹤0.01% |
16,695
-149,691
| -90% | -$1.73M |
|
1347
Voyager Therapeutics
VYGR
$243M
| $193K | ﹤0.01% |
+32,996
| New | +$193K |
|
1348
Kearny Financial
KRNY
$421M
| $190K | ﹤0.01% |
27,619
+8,684
| +46% | +$59.7K |
|
|
GRDN
1349
Guardian Pharmacy Services, Inc.
GRDN
$1.92B
| $190K | ﹤0.01% |
+11,322
| New | +$190K |
|
1350
Nuvation Bio
NUVB
$1.15B
| $189K | ﹤0.01% |
+82,447
| New | +$189K |
|